SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007824
Filing Date
2022-05-09
Accepted
2022-05-09 16:13:14
Documents
86
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cara-20220331x10q.htm   iXBRL 10-Q 1856685
2 EX-10.1 cara-20220331xex10d1.htm EX-10.1 14217
3 EX-31.1 cara-20220331xex31d1.htm EX-31.1 12106
4 EX-31.2 cara-20220331xex31d2.htm EX-31.2 11781
5 EX-32.1 cara-20220331xex32d1.htm EX-32.1 10137
  Complete submission text file 0001558370-22-007824.txt   8876031

Data Files

Seq Description Document Type Size
6 EX-101.SCH cara-20220331.xsd EX-101.SCH 62739
7 EX-101.CAL cara-20220331_cal.xml EX-101.CAL 61033
8 EX-101.DEF cara-20220331_def.xml EX-101.DEF 312270
9 EX-101.LAB cara-20220331_lab.xml EX-101.LAB 522378
10 EX-101.PRE cara-20220331_pre.xml EX-101.PRE 482203
80 EXTRACTED XBRL INSTANCE DOCUMENT cara-20220331x10q_htm.xml XML 1610157
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 22905085
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences